全球膠囊內視鏡市場：市場規模、佔有率和趨勢分析（2025-2032 年）

2025年全球膠囊內視鏡市場價值超過4.87億美元。預計到2031年，該市場將達到6.23億美元，年複合成長率為3.6%。

本報告涵蓋用於胃腸道診斷程序的膠囊內視鏡設備和資料記錄器。報告量化了銷售量、平均售價、市場價值、成長率和企業市場占有率。此外，報告還分析了市場促進因素和限制因素、近期併購、召回事件和技術趨勢。報告提供截至2021年的歷史數據，並預測至2031年。

這反映了醫療系統如何將膠囊內視鏡技術融入小腸、食道和結腸的各種診斷流程。這項技術不僅因其能夠取代某些傳統手術而受到評估，還因其在提高患者舒適度、擴大篩檢覆蓋範圍和改善疾病早期發現方面的作用而受到關注。

市場概覽

膠囊內視鏡技術使醫生能夠利用可吞嚥的攝影膠囊觀察胃腸道，可將數千張影像無線傳輸至外部記錄儀。此技術屬於非侵入性檢查，患者只需極少的準備工作，即可獲得傳統內視鏡通常無法觸及的部位的放大影像。

預計到2025年，膠囊內視鏡將佔全球市場的大部分佔有率。其成長主要得益於臨床應用的不斷擴大、醫保覆蓋範圍的擴大以及影像解析度和電池續航能力的持續提升。膠囊內視鏡已從最初用於診斷不明原因消化道出血的小眾工具，發展成為小腸評估、發炎性腸道疾病（IBD）和疑似克隆氏症的主流診斷工具。

預計在預測期內，食道和結腸領域應用範圍的擴大將進一步推動市場需求。正在進行的臨床試驗表明，這些領域具有強大的診斷優勢，尤其是在將膠囊平台與磁性控制系統整合以實現部分導航引導時。同時，對機器人驅動和基於人工智慧的病變檢測的研究正在為下一代完全可控的半自動診斷膠囊奠定基礎。

• 儘管膠囊內視鏡目前仍主要用於診斷，但隨著製造商持續投資克服兩大技術瓶頸——對膠囊運動的控制有限以及無法進行治療性介入——市場前景依然光明。為解決這些問題，目前的研究方向包括外部磁力轉向、可變影格速率攝影機以及能夠進行組織取樣和標靶治療的繫繩式膠囊原型。

醫療機構報告稱，膠囊內視鏡檢查比傳統內視鏡檢查更舒適，所需資源更少。傳統內視鏡檢查需要鎮靜、專門的設施和恢復時間。簡化的工作流程符合門診病人和日間護理的發展趨勢，使醫院能夠將胃腸道診斷擴展到非急性護理環境和家庭監測項目。

人口老化、胃腸道疾病盛行率上升以及人們對非侵入性診斷方案的日益關注，進一步推動了市場的發展勢頭。隨著膠囊內視鏡系統的影像品質、人工智慧輔助分析和資料整合能力的不斷提升，預計其在已開發經濟體和新興經濟體的醫療保健市場中的應用將不斷成長。

市場促進因素

最低限度的培訓

醫生只需接受少量額外訓練即可進行膠囊內視鏡檢查。其核心技能與傳統內視鏡檢查基本相同，尤其是在影像判讀方面。學習曲線主要集中在操作膠囊設備以及用於影像檢視和記錄的配套軟體平台。這種簡單性使其易於在醫院和門診機構快速推廣，並支援在專科醫生資源有限的胃腸病學網路中部署。

患者的偏好和舒適度

患者接受度是膠囊內視鏡市場的關鍵促進因素。作為一種非侵入性檢查，膠囊內視鏡插入、鎮靜和充氣過程均不會引起不適。此檢查通常可在患者的日常生活中完成，從而減輕焦慮並提高後續檢查的依從性。在大規模篩檢計畫中，尤其是在小腸和早期大腸疾病的篩檢中，患者的舒適度是決定參與率的關鍵因素。

擴大報銷範圍

優惠的報銷政策正在擴大全球範圍內的醫療服務覆蓋範圍。在許多地區，如果傳統內視鏡檢查結果不明確，膠囊內視鏡檢查已納入健保報銷範圍，用於小腸檢查。專業胃腸病學會的持續計劃促成了食道和結腸膠囊內視鏡檢查的醫保報銷，這有望進一步擴大公立和私立醫療體系的醫療服務覆蓋範圍。

技術進步

相機解析度、電池續航時間和無線資料傳輸技術的進步顯著提高了診斷準確率。能夠識別出血、潰瘍和息肉等異常情況的人工智慧軟體縮短了閱片時間，並降低了閱片者之間的差異。同時，磁導航系統和機器人平台正被評估其提供即時定位控制的潛力，這是實現全面手術流程整合的關鍵一步。

市場限制

技術限制

膠囊內視鏡僅提供診斷功能，無法像傳統內視鏡那樣採集切片檢查樣本。如果檢測到病灶或息肉，則需要進行後續的傳統內視鏡檢查以確認診斷並進行組織取樣。這種兩步驟流程增加了成本，也給患者帶來了不便。在基於膠囊的切片檢查和治療功能實現商業性化之前，這一限制可能會繼續限制其作為傳統內視鏡的完全替代方案的潛力。

設備成本高且重複使用性有限

雖然膠囊內視鏡檢查省去了鎮靜和恢復設備的相關費用，但膠囊本身仍然是一種高成本的一次性醫療器材。在對成本較為敏感的地區，醫院和門診診所可能不願大規模採用膠囊內視鏡檢查，尤其是在報銷不全或延遲的情況下。

資料處理負擔

每個膠囊都會產生數千張需要臨床醫生審核的影像。雖然人工智慧輔助軟體有助於縮短閱片時間，但仍需人工審核，這會加重繁忙中心的診斷工作負擔。因此，亟需持續開放自動化、雲端基礎分析和整合工作流程管理工具。

對膠囊運輸的控制有限

膠囊在胃腸道內的被動移動可能導致檢查不完整，並可能在腸狹窄患者中造成膠囊滯留。儘管磁控和基於感測器的定位技術取得了顯著進展，但這些風險仍然存在，並持續阻礙傳統醫療機構採用該技術。

競爭分析

到了2025年，全球膠囊內視鏡市場將由美敦力主導，該公司憑藉其PillCam™平台佔大部分市場佔有率。Medtronic在北美和西歐保持了領先地位，在全球範圍內位居第二，僅次於建山科技。Medtronic的市場地位源自於2015年對柯惠醫療的收購，而柯惠醫療先前已收購了膠囊內視鏡技術的原創者Given Imaging公司。

2025年，建山科技（OMOM™）在全球排名第二。該公司總部位於中國當地，其膠囊內視鏡系統銷往亞洲、澳洲和拉丁美洲。其產品系列包括採用專有資料記錄技術的小腸和食道膠囊內視鏡。

安康醫療科技公司預計到2025年將躋身全球市佔率第三名。安康總部位於中國武漢，已研發並商業化了NaviCam™可控胃膠囊系統。該系統是一種取得專利的磁性機器人膠囊引導平台，可使臨床醫生控制膠囊在胃內的移動。目前，該系統已在中國100多家醫療中心投入使用，並正在評估其國際推廣的可能性。

到2025年，這三家公司將佔全球市場佔有率的大部分。規模較小的參與企業和區域經銷商活躍於區隔市場和早期市場，尤其是在東南亞、拉丁美洲和中東地區。市場集中度仍然很高，這反映了膠囊成像系統相關的技術複雜性和監管要求。

目標市場和數據範圍

定量覆蓋

市場規模、市佔率、市場預測、成長率、銷售量、平均售價

定性覆蓋

市場成長趨勢、市場限制因素、競爭分析及主要競爭對手的SWOT分析、併購、公司簡介、產品系列、FDA召回事件、顛覆性技術以及影響需求的疾病概述

時期

基準年為2025年，預測期間為2026-2032年，歷史資料為2022-2024年。

數據來源

對行業領袖的初步訪談、政府醫生資料、監管資料、私人醫院資料、進出口資料以及iData Research的內部醫療技術資料庫。

調查方法注記

它透過一手和二手資料以及跨區域的程式資料、裝置量和使用假設檢驗。

醫療環境

醫院、專科診所、門診手術中心及診斷影像中心

地區

北美、歐洲、亞太地區、拉丁美洲、中東和非洲

調查方法附錄和縮寫詞彙表提供了定義和假設。

目錄

圖表清單

圖表列表

調查方法

全球關稅的影響

膠囊內視鏡市場

• 摘要整理
  • 全球膠囊內視鏡市場概覽
  • 競爭分析
  • 目標區域
• 介紹
• 手術次數
• 市場概覽
  • 按區隔市場
  • 按地區
• 市場分析與預測
  • 膠囊內視鏡市場整體狀況
  • 相機膠囊市場
  • 資料記錄器市場
• 推動和阻礙因素
• 競爭市佔率分析

簡稱

The global capsule endoscopy market was valued at over $487 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 3.6%, reaching $623 million by 2031.

This report covers camera capsule endoscopy devices and data recorders used in gastrointestinal diagnostic procedures. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers and limiters, recent mergers and acquisitions (M&A), recalls, and technology trends. It includes historical data to 2021 and provides forecasts until 2031.

The scope reflects how healthcare systems are integrating capsule endoscopy into broader diagnostic pathways for the small intestine, esophagus, and colon. The technology is being evaluated not only for its ability to replace certain conventional procedures but also for its role in enhancing patient comfort, expanding screening access, and improving early disease detection.

Market Overview

Capsule endoscopy enables physicians to visualize the gastrointestinal (GI) tract using a swallowable camera capsule that transmits thousands of images wirelessly to an external recorder. The procedure is noninvasive, requires minimal patient preparation, and offers extended imaging of regions often inaccessible by conventional endoscopes.

In 2025, the camera capsule segment accounted for the majority of global market value. Growth is supported by expanding clinical adoption, broader reimbursement coverage, and continued advances in imaging resolution and battery life. Capsule endoscopy has evolved from a niche tool for obscure GI bleeding to a mainstream diagnostic modality for small bowel evaluation, inflammatory bowel disease (IBD), and suspected Crohn's disease.

Over the forecast period, expansion into esophageal and colonic applications is expected to further accelerate demand. Ongoing trials are demonstrating strong diagnostic yield in these areas, particularly as capsule platforms integrate with magnetic control systems that allow partial navigational guidance. In parallel, research into robotic actuation and AI-based lesion detection is laying the groundwork for the next generation of fully controllable and semi-automated diagnostic capsules.

• Although capsule endoscopy remains primarily diagnostic, the market outlook is positive as manufacturers continue to invest in overcoming its two main technical constraints: limited control over capsule movement and the inability to perform therapeutic interventions. Efforts to address these issues include external magnetic steering, variable frame-rate cameras, and tethered capsule prototypes capable of sampling tissue or delivering targeted therapy.

Healthcare providers value capsule endoscopy for its patient comfort and reduced resource requirements compared to traditional endoscopy, which demands sedation, specialized facilities, and recovery time. The simplified workflow aligns with outpatient and ambulatory care trends, enabling hospitals to extend GI diagnostics to non-acute environments and even home-based monitoring programs.

Market momentum is further supported by aging populations, increasing gastrointestinal disease prevalence, and growing awareness of noninvasive diagnostic options. As capsule systems continue to improve in image quality, AI-assisted analytics, and data integration, adoption is expected to broaden across developed and emerging healthcare markets.

Market Drivers

Minimal Training Required

Physicians require little additional training to perform capsule endoscopy. The core skill set overlaps with conventional endoscopy, particularly in image interpretation. The incremental learning curve primarily involves the operation of capsule devices and associated software platforms for image review and documentation. This simplicity facilitates faster adoption in hospital and outpatient settings and supports deployment across gastroenterology networks with limited specialist capacity.

Patient Preference and Comfort

Patient acceptance is a significant driver of the capsule endoscopy market. The noninvasive nature of the procedure eliminates discomfort associated with insertion, sedation, or air insufflation. The test can often be completed within the patient's daily routine, reducing anxiety and improving compliance for follow-up examinations. In population screening programs, particularly for small bowel and early colorectal disease detection, patient comfort is a critical determinant of participation rates.

Reimbursement Expansion

Favorable reimbursement policies are broadening global access. In many regions, capsule endoscopy is now reimbursed for small bowel investigation following inconclusive traditional endoscopy results. Continued advocacy by professional gastroenterology societies is helping establish reimbursement for esophageal and colonic capsule procedures, which will further expand utilization across both public and private healthcare systems.

Technological Advancements

Improvements in camera resolution, battery life, and wireless data transmission have greatly enhanced diagnostic accuracy. AI-based software capable of identifying abnormalities such as bleeding, ulcers, and polyps is reducing interpretation time and variability among readers. Meanwhile, magnetic navigation systems and robotic platforms are being evaluated for their potential to provide real-time positioning control, a key step toward full procedural integration.

Market Limiters

Technological Limitations

Capsule endoscopy serves only a diagnostic function and cannot collect biopsy samples, a feature readily available with conventional endoscopy. When lesions or polyps are detected, a follow-up traditional endoscopy is required for confirmation and tissue sampling. This two-step workflow increases cost and patient inconvenience. Until capsule-based biopsy or therapeutic capabilities are commercially available, this limitation will continue to constrain its full replacement potential.

High Device Cost and Reusability Constraints

While capsule endoscopy eliminates costs related to sedation and recovery facilities, the capsule itself remains a high-cost, single-use device. Hospitals and outpatient clinics in cost-sensitive markets may hesitate to adopt capsule endoscopy at scale, particularly where reimbursement remains incomplete or delayed.

Data Processing Burden

Each capsule produces thousands of images that require review by clinicians. Although AI-assisted software helps reduce reading time, manual verification is still necessary, which can strain diagnostic workloads in busy facilities. This creates a need for continued development in automation, cloud-based analysis, and integrated workflow management tools.

Limited Control Over Capsule Transit

The capsule's passive movement through the GI tract can result in incomplete studies or retention in patients with strictures. Despite significant progress in magnetic control and sensor-based localization, these risks persist and represent ongoing barriers to adoption among conservative providers.

Competitive Analysis

The global capsule endoscopy market in 2025 was dominated by Medtronic, which accounted for the majority of market share through its PillCam(TM) platform. Medtronic maintained leading positions in North America and Western Europe, while ranking second globally behind Jianshan Science and Technology. Medtronic's position stems from its acquisition of Covidien in 2015, which previously acquired Given Imaging, the original innovator of capsule endoscopy.

Jianshan Science and Technology (OMOM(TM)) ranked second globally in 2025. Headquartered in mainland China, the company distributes its capsule endoscopy systems across Asia, Australia, and Central and South America. Its product portfolio includes both small bowel and esophageal capsules supported by proprietary data-recording technology.

Ankon Medical Technologies held the third-largest global share in 2025. Based in Wuhan, China, Ankon developed and commercialized the NaviCam(TM) Controllable Stomach Capsule System, a patented magnetic robotic capsule guidance platform that allows clinicians to direct capsule movement within the stomach. This system is now deployed in over one hundred medical centers in China and is being evaluated for broader international expansion.

Together, these three companies accounted for the vast majority of global market share in 2025. Smaller participants and regional distributors are active in niche or early-stage markets, particularly in Southeast Asia, Latin America, and the Middle East. Market concentration remains high, reflecting the technological complexity and regulatory requirements associated with capsule-based imaging systems.

Market Coverage and Data Scope

Quantitative Coverag

Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.

Qualitative Coverag

Market growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, FDA recalls, disruptive technologies, and disease overviews influencing demand.

Time Frame

Base year 2025, forecasts 2026-2032, historical data 2022-2024.

Data Source

Primary interviews with industry leaders, government physician data, regulatory data, hospital private data, import and export data, and iData Research's internal MedTech database.

Methodology Note

Revenue is modeled from units multiplied by ASP, validated through primary and secondary sources, and cross-checked with procedure data, installed base, and utilization assumptions across regions.

Care Settings

Hospitals, specialty clinics, ambulatory surgical centers, and diagnostic imaging centers.

Geography

This edition covers the global market with analysis across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Methodology appendix and acronym glossary documenting definitions and assumptions.

Why This Report

Where is the largest and fastest-growing opportunity within capsule endoscopy, and which product categories are most likely to gain share over the forecast period?

How does the capsule endoscopy market relate to the broader GI diagnostic landscape, including traditional endoscopy, imaging, and AI-assisted detection platforms?

What forces will shape the market going forward, including reimbursement coverage, magnetic navigation systems, AI-based lesion detection, and integration into hospital and outpatient diagnostic workflows?

How do technological advancements in capsule design, power management, and image processing influence pricing, adoption, and replacement cycles?

Which product designs are gaining traction in capsule navigation and data recorders, and how are hospitals prioritizing image quality and workflow efficiency?

What is the impact of diagnostic-only limitations and device retention on purchasing decisions and technology preference among gastroenterologists?

How can suppliers strengthen their business case by linking noninvasive diagnostics, patient satisfaction, and workflow optimization to cost control and clinical productivity?

How should commercial teams plan for market expansion across emerging regions, reimbursement variations, and competition from conventional endoscopy platforms?

Where are the key risks to growth, including pricing pressure, incomplete reimbursement, and technological constraints on therapeutic functionality?

The Global Capsule Endoscopy Market Report from iData Research answers these questions with procedure-based models, company share analysis, and detailed pricing data. Use it to quantify demand by segment, forecast technology trends, plan product launches, and set pricing and partnership strategies aligned with evolving clinical practice.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Capsule Endoscopy Market

• 5.1 Executive Summary
  • 5.1.1 Global Capsule Endoscopy Market Overview
  • 5.1.2 Competitive Analysis
  • 5.1.3 Regions Included
• 5.2 Introduction
• 5.3 Procedure Numbers
• 5.4 Market Overview
  • 5.4.1 By Segment
  • 5.4.2 By Region
• 5.5 Market Analysis And Forecast
  • 5.5.1 Total Capsule Endoscopy Market
  • 5.5.2 Camera Capsule Market
  • 5.5.3 Data Recorder Market
• 5.6 Drivers And Limiters
  • 5.6.1 Market Drivers
  • 5.6.2 Market Limiters
• 5.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 5-1: Capsule Endoscopy Market, Global, 2025 & 2032
• Chart 5-2: Capsule Endoscopy Procedures, Global, 2025
• Chart 5-3: Capsule Endoscopy Procedures by Region, Global, 2022 - 2032
• Chart 5-4: Capsule Endoscopy Market, Global, 2022 - 2032
• Chart 5-5: Capsule Endoscopy Market by Region, Global, 2022 - 2032
• Chart 5-6: Leading Competitors, Capsule Endoscopy Market, Global, 2025

LIST OF FIGURES

• Figure 5-1: Capsule Endoscopy Regions Covered, Global (1 of 2)
• Figure 5-2: Capsule Endoscopy Regions Covered, Global (2 of 2)
• Figure 5-3: Capsule Endoscopy Procedures by Region, Global, 2022 - 2032
• Figure 5-4: Capsule Endoscopy Procedures by Country, North America, 2022 - 2032
• Figure 5-5: Capsule Endoscopy Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 5-6: Capsule Endoscopy Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 5-7: Capsule Endoscopy Procedures by Country, Western Europe, 2022 - 2032
• Figure 5-8: Capsule Endoscopy Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 5-9: Capsule Endoscopy Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 5-10: Capsule Endoscopy Procedures by Country, Middle East, 2022 - 2032
• Figure 5-11: Capsule Endoscopy Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 5-12: Capsule Endoscopy Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 5-13: Capsule Endoscopy Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 5-14: Capsule Endoscopy Procedures by Country, Africa, 2022 - 2032
• Figure 5-15: Capsule Endoscopy Market by Segment, Global., 2022 - 2032 (US$M)
• Figure 5-16: Capsule Endoscopy Market by Region, Global, 2022 - 2032 (US$M)
• Figure 5-17: Capsule Endoscopy Market, U.S., 2022 - 2032
• Figure 5-18: Units Sold by Region, Capsule Endoscopy Market, Global, 2022 - 2032
• Figure 5-19: Average Selling Price by Region, Capsule Endoscopy Market, Global, 2022 - 2032 (US$)
• Figure 5-20: Market Value by Region, Capsule Endoscopy Market, Global, 2022 - 2032 (US$M)
• Figure 5-21: Camera Capsule Market, U.S., 2022 - 2032
• Figure 5-22: Units Sold by Region, Camera Capsule Market, Global, 2022 - 2032
• Figure 5-23: Average Selling Price by Region, Camera Capsule Market, Global, 2022 - 2032 (US$)
• Figure 5-24: Market Value by Region, Camera Capsule Market, Global, 2022 - 2032 (US$M)
• Figure 5-25: Data Recorder Market, U.S., 2022 - 2032
• Figure 5-26: Units Sold by Region, Data Recorder Market, Global, 2022 - 2032
• Figure 5-27: Average Selling Price by Region, Data Recorder Market, Global, 2022 - 2032 (US$)
• Figure 5-28: Market Value by Region, Data Recorder Market, Global, 2022 - 2032 (US$M)
• Figure 5-29: Leading Competitors, Capsule Endoscopy Market, Global, 2025